Company Quick10K Filing
Verso Quinnesec
10-Q 2021-03-31 Filed 2021-05-07
10-K 2020-12-31 Filed 2021-03-01
10-Q 2020-09-30 Filed 2020-11-12
10-Q 2020-06-30 Filed 2020-08-06
10-Q 2020-03-31 Filed 2020-05-11
10-K 2019-12-31 Filed 2020-03-02
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-08
10-K 2018-12-31 Filed 2019-03-01
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-08
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-03-08
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-09
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-20
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-23
10-K 2015-12-31 Filed 2016-04-14
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-11
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-10
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-07
10-K 2013-12-31 Filed 2014-03-06
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-05-09
10-K 2012-12-31 Filed 2013-03-07
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-09
10-Q 2012-03-31 Filed 2012-05-14
10-K 2011-12-31 Filed 2012-03-06
10-Q 2011-09-30 Filed 2011-11-07
10-Q 2011-06-30 Filed 2011-08-11
10-Q 2011-03-31 Filed 2011-05-09
10-K 2010-12-31 Filed 2011-03-03
10-Q 2010-09-30 Filed 2010-11-03
10-Q 2010-06-30 Filed 2010-08-11
10-Q 2010-03-31 Filed 2010-05-06
10-K 2009-12-31 Filed 2010-03-03
8-K 2020-11-09
8-K 2020-09-30
8-K 2020-08-05
8-K 2020-06-24
8-K 2020-06-09
8-K 2020-06-01
8-K 2020-05-12
8-K 2020-05-11
8-K 2020-04-13
8-K 2020-03-13
8-K 2020-03-10
8-K 2020-02-27
8-K 2020-02-18
8-K 2020-02-10
8-K 2020-01-31
8-K 2020-01-30
8-K 2020-01-23
8-K 2020-01-07
8-K 2019-12-23
8-K 2019-12-16
8-K 2019-12-10
8-K 2019-11-12
8-K 2019-11-11
8-K 2019-11-11
8-K 2019-10-03
8-K 2019-08-08
8-K 2019-06-17
8-K 2019-06-13
8-K 2019-05-08
8-K 2019-04-30
8-K 2019-04-05
8-K 2019-02-28
8-K 2019-02-06
8-K 2018-11-07
8-K 2018-09-24
8-K 2018-09-24
8-K 2018-08-16
8-K 2018-08-08
8-K 2018-07-13
8-K 2018-07-05
8-K 2018-05-09
8-K 2018-03-20
8-K 2018-03-08
8-K 2018-01-16

Verso Quinnesec Financials

VRS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-06-302016-09-302016-12-312017-09-302018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash565295561062131091147126141410440266910928898
Accounts Receivable9710184
Inventory196199167193141131160152138138155144129111536559540484485498399398373377398473459416
PP&E9519499359078191,4727627557421,5247227036881,2352,0532,0061,9312,7311,6941,6681,0741,0471,0471,0261,3151,007930940
Assets1,4861,4651,4441,3981,2161,2321,1551,1381,1181,1221,0861,0611,0439013,0512,9932,9172,7332,5832,5231,7621,7411,7091,7291,6991,7661,6591,635
Accounts Payable1271291111139492948083889681886320619217011388109157194216210215210210207
Long-Term Debt1,2581,2601,2621,3681,2221,2481,2831,2801,2951,2721,3691,3591,3701,3502,8232,8162,9332,9024432,6004542642031621080455024
Liabilities1,5441,5271,5751,5981,5371,5311,5071,5321,5211,5331,5871,6041,6211,6813,8573,8573,8913,9123,8503,8251,057995959891793822824768
Stockholders' Equity-247-221-352-394-403-411-501-543-578-780-806-864-974-1,179-1,267-1,302705746750838906944835867
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-06-302016-09-302016-12-312017-09-302018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue399457450375373361333330375350299321350326806778782756690635630639644704695639602616
Cost of Revenue310288303665579
Gross Profit51632391116
R&D
SG&A22191819171819191818181818175546335347407-3625282524242923
Tax00-0-0-1000-100-1-2-20-100000010-1
Net Income-231-68-72-10328-38-43-10-20-91-43-36-184-122-60-111-129-88-33-21868636-11230
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-06-302016-09-302016-12-312017-09-302018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating1362-7049-8319-339-9628-011-20419-9964-2586771-462362
Cash Investing-17-19-173833-19-13-14-9-12-72167-17-2349-18-14-24-5-18-21-36
Cash Financing-0-049-351-315-2298-1312-2045-2118-77296-42-6744-1-27